Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | TOP2A | P11388 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9895595 | 0.93 | EPHX2 (0.59) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL2815973 | 0.88 | ALOX15 (0.64) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL2817894 | 0.88 | ALOX15 (0.64) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL2815571 | 0.88 | ALOX15 (0.64) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL2817144 | 0.88 | ALOX15 (0.64) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL990700 | 0.87 | EPHX2 (0.58) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL2815756 | 0.86 | ALOX15 (0.65) | ALOX15TOP2AEPHX2CYP1A2CYP3A4 | |
| SCHEMBL20723822 | 0.84 | PTGS1 (0.64) | ALOX15TOP2AEPHX2CYP3A4 | |
| SCHEMBL20723797 | 0.84 | PTGS1 (0.64) | ALOX15TOP2AEPHX2CYP3A4 | |
| SCHEMBL20723701 | 0.84 | PTGS1 (0.64) | ALOX15TOP2AEPHX2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2614727-B1 | N-Nonanoylvanillylamine as an appetite reduction agent and as a means for generating the feeling of being full and corresponding orally consumable products and method | SYMRISE AG (DE) | 2016-09-07 | — | — | EP | claimed |
| EP-2918270-A1 | Derivatives of aromatic alkenoic acids for curbing appetite and enhancing mood | Symrise AG (DE) | 2015-09-16 | — | — | EP | claimed |
| EP-2614727-A1 | N-Nonanoylvanillylamine as an appetite reduction agent, as a means for generating the feeling of being full and as a mood enhancer and corresponding material mixtures, orally consumable products and method | Symrise AG (DE) | 2013-07-17 | — | — | EP | claimed |
| EP-3911172-B1 | COMBINATION OF SATIETY COMPONENTS WITH ARGININE | SYMRISE AG (DE) | 2026-04-15 | — | — | EP | disclosed |
| CN-117241815-A | Composition and method for producing the same | 奇华顿股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-116003276-A | Method for synthesizing capsaicin by utilizing micro-reaction chip | 上海化学试剂研究所有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-112608247-B | Preparation method of capsaicin and capsaicin prepared by using same | 遂宁晶安科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115427002-A | Method for producing solid cosmetic and press head | 株式会社资生堂 | 2022-12-02 | — | — | CN | disclosed |
| CN-115160175-A | Preparation method of capsaicin salt | 遂宁晶安科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-110305031-B | Preparation method of capsaicin and capsaicin prepared by using same | 遂宁晶安科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-109689019-B | Compositions and products | 株式会社资生堂 | 2022-02-22 | — | — | CN | disclosed |
| WO-2017220168-A1 | CINNAMYL ALCOHOL DERIVATIVE FOR REDUCING APPETITE AND FOR GENERATING THE FEELING OF BEING FULL | SYMRISE AG (DE) | 2017-12-28 | — | — | WO | disclosed |
| EP-2614727-B1 | N-Nonanoylvanillylamine as an appetite reduction agent and as a means for generating the feeling of being full and corresponding orally consumable products and method | SYMRISE AG (DE) | 2016-09-07 | — | — | EP | disclosed |
| EP-2614727-B1 | N-Nonanoylvanillylamine as an appetite reduction agent and as a means for generating the feeling of being full and corresponding orally consumable products and method | SYMRISE AG (DE) | 2016-09-07 | — | — | EP | disclosed |
| EP-2918270-A1 | Derivatives of aromatic alkenoic acids for curbing appetite and enhancing mood | Symrise AG (DE) | 2015-09-16 | — | — | EP | disclosed |
| EP-2614727-A1 | N-Nonanoylvanillylamine as an appetite reduction agent, as a means for generating the feeling of being full and as a mood enhancer and corresponding material mixtures, orally consumable products and method | Symrise AG (DE) | 2013-07-17 | — | — | EP | disclosed |
| EP-2614727-A1 | N-Nonanoylvanillylamine as an appetite reduction agent, as a means for generating the feeling of being full and as a mood enhancer and corresponding material mixtures, orally consumable products and method | Symrise AG (DE) | 2013-07-17 | — | — | EP | disclosed |
| EP-2614727-A1 | N-Nonanoylvanillylamine as an appetite reduction agent, as a means for generating the feeling of being full and as a mood enhancer and corresponding material mixtures, orally consumable products and method | Symrise AG (DE) | 2013-07-17 | — | — | EP | disclosed |
| US-20120065221-A1 | Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use | THERAQUEST BIOSCIENCES, INC. (PA) | 2012-03-15 | — | — | US | disclosed |
| CN-1424090-A | Chinese medicine preparation for treating toothache and producing method thereof | SUO RONGBIN (CN) | 2003-06-18 | — | — | CN | disclosed |